Comparison of Video Consent Versus Routine Consent for Participation in Research Studies

NCT ID: NCT00430391

Last Updated: 2013-06-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

382 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-12-31

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine a novel technique for improving the informed consent process for participation in research by the older psychiatric population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will test a new method of delivering informed consent procedures to people with schizophrenia. The study has two aims. First, it will examine the impact of a multimedia DVD-based informed consent process on the ability of participants to make decisions regarding participation in research, both after the initial presentation of information and after 1 month. Second, it will examine the association between participant personal characteristics and the benefit derived from the DVD-based informed consent process.

Participants with schizophrenia and a normal comparison group will participate in either a routinely used informed consent procedure or an enhanced, DVD-based informed consent procedure. The outcome measure, comprehension of the consent materials, including understanding of the risks and benefits of participating in the study, will be assessed in each group. It is expected that the normal control group will reach the requisite level of comprehension faster than the schizophrenia group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DVD patient high risk

Patients with a diagnosis of schizophrenia/schizoaffective disorder randomized to the DVD, high risk version

Group Type EXPERIMENTAL

DVD Consent

Intervention Type OTHER

Participants are randomized to DVD enhanced consent that is either high risk or low risk.

DVD patient low risk

Patient with a diagnosis of schizophrenia/schizoaffective disorder randomized to DVD consent, low risk version

Group Type EXPERIMENTAL

DVD Consent

Intervention Type OTHER

Participants are randomized to DVD enhanced consent that is either high risk or low risk.

DVD normal high risk

Participants with no psychiatric diagnosis randomized to DVD consent, high risk version

Group Type EXPERIMENTAL

DVD Consent

Intervention Type OTHER

Participants are randomized to DVD enhanced consent that is either high risk or low risk.

DVD normal low risk

Participants with no psychiatric diagnosis randomized to DVD consent, low risk version

Group Type EXPERIMENTAL

DVD Consent

Intervention Type OTHER

Participants are randomized to DVD enhanced consent that is either high risk or low risk.

Routine control high risk

Participants with no psychiatric diagnosis randomized to routine consent, high risk version

Group Type EXPERIMENTAL

Routine Control

Intervention Type OTHER

Participants are assigned to the routine, standard consent.

Routine control low risk

Participants with no psychiatric diagnosis randomized to routine consent, low risk version

Group Type EXPERIMENTAL

Routine Control

Intervention Type OTHER

Participants are assigned to the routine, standard consent.

Routine patient low risk

Participants with schizophrenia/schizoaffective disorder randomized to routine consent, low risk version

Group Type EXPERIMENTAL

Routine Control

Intervention Type OTHER

Participants are assigned to the routine, standard consent.

Routine patient high risk

Participants with schizophrenia/schizoaffective disorder randomized to routine consent, high risk version

Group Type EXPERIMENTAL

DVD Consent

Intervention Type OTHER

Participants are randomized to DVD enhanced consent that is either high risk or low risk.

Routine Control

Intervention Type OTHER

Participants are assigned to the routine, standard consent.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DVD Consent

Participants are randomized to DVD enhanced consent that is either high risk or low risk.

Intervention Type OTHER

Routine Control

Participants are assigned to the routine, standard consent.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* DSM-IV diagnosis of schizophrenia or no current or past major neuropsychiatric disorder (normal subjects)
* Fluency in English
* Written informed consent

Exclusion Criteria

* Known or suspected dementia
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

University of California, San Diego

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dilip V. Jeste

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dilip V. Jeste, MD

Role: PRINCIPAL_INVESTIGATOR

UCSD

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California, San Diego

San Diego, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01MH067902

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01MH067902

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.